Clinical Trial Update: A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating nevirapine to prevent mother-to-child transmission of HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Pregnancy

Drugs mentioned

• NEVIRAPINE (nevirapine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Pregnancy | Phase 3 | Status: COMPLETED